Related Experiment Videos
Cholestasis in Crohn's disease: a diagnostic challenge
N Hilzenrat1, E Lamoureux, A Sherker
1Division of Gastroenterology, Sir Mortimer B Davis-Jewish General Hospital, McGill University, Montreal, Quebec.
Summary
Crohn's disease patients may experience recurrent cholestatic liver disease due to drug reactions or inflammation. Prompt investigation is crucial for managing these serious hepatobiliary complications.
Area of Science:
- Gastroenterology and Hepatology
- Internal Medicine
Background:
- Inflammatory bowel disease (IBD), including Crohn's disease, is associated with various extraintestinal manifestations.
- Hepatobiliary complications can occur in IBD patients, necessitating careful monitoring and investigation.
Observation:
- A case study details a 24-year-old male with Crohn's disease experiencing three distinct episodes of cholestatic liver disease over eight years.
- The first episode was linked to sulfasalazine, the second to colitis exacerbation with portal inflammation, and the third to granulomatous hepatitis during quiescent disease.
Findings:
- Cholestatic liver disease episodes in this Crohn's patient were associated with different triggers: drug reaction, disease activity, and idiopathic granulomatous hepatitis.
- Liver biopsy revealed moderate portal inflammation in one episode, while another showed granulomatous hepatitis.
Implications:
- This case highlights the diverse and potentially serious hepatobiliary complications that can arise in Crohn's disease patients.
- Early and thorough investigation of liver dysfunction is recommended in IBD patients to ensure timely diagnosis and management.